1996;94:376 83. 482. Misaki T, Watanabe G, Iwa T, et al. Surgical treatment of patients with Wolff-Parkinson-White syndrome and associated Ebstein s anomaly. J Thorac Cardiovasc Surg. 1995;110:1702 7. 483. Khositseth A, Danielson GK, Dearani JA, et al. Supraventricular tachyar- rhythmias in Ebstein anomaly: management and outcome. J Thorac Cardiovasc Surg. 2004;128:826 33. 484. Bockeria L, Golukhova E, Dadasheva M, et al. Advantages and disadvan- tages of one-stage and two-stage surgery for arrhythmias and Ebstein s anomaly. Eur J Cardiothorac Surg. 2005;28:536 40. 485. Pressley JC, Wharton JM, Tang AS, et al. Effect of Ebstein s anomaly on short- and long-term outcome of surgically treated patients with Wolff- Parkinson-White syndrome. Circulation. 1992;86:1147 55. 486. Khairy P, Harris L, Landzberg MJ, et al. Sudden death and defibrillators in transposition of the great arteries with intra-atrial baffles: a multicenter study. Circ Arrhythm Electrophysiol. 2008;1:250 7. 487. Banchs JE, Baquero GA, Nickolaus MJ, et al. Clinical efficacy of dofeti- lide for the treatment of atrial tachyarrhythmias in adults with congenital heart disease. Congenit Heart Dis. 2014;9:221 7. 488. Tanel RE, Walsh EP, Lulu JA, et al. Sotalol for refractory arrhythmias in pediatric and young adult patients: initial efficacy and long-term out- come. Am Heart J. 1995;130:791 7. 489. Lukac P, PedersenAK, Mortensen PT, et al.Ablation of atrial tachycardia after surgery for congenital and acquired heart disease using an electro- anatomic mapping system: which circuits to expect in which substrate? Heart Rhythm. 2005;2:64 72. 490. Yap S-C, Harris L, Downar E, et al. Evolving electroanatomic sub- strate and intra-atrial reentrant tachycardia late after Fontan surgery. J Cardiovasc Electrophysiol. 2012;23:339 45. 491. Wu J, Deisenhofer I, Ammar S, et al. Acute and long-term outcome af- ter catheter ablation of supraventricular tachycardia in patients after the Mustard or Senning operation for D-transposition of the great arteries. 